Indicators for Gleevec nonadherence were cognitive functioning, global health status score, social support, gender and others ...

The Food and Drug Administration has accepted and granted priority review to a new drug application for sunvozertinib.

Subcutaneous Sarclisa, administered via OBDS, showed non-inferior efficacy to IV Sarclisa in relapsed/refractory multiple ...

Obtaining a second opinion during your cancer treatment can be a daunting but also life-changing step; however, surprisingly ...

The investigational anti-PD-1 monoclonal antibody is showing positive topline results from the phase 3 CREST trial.

Dr. Balazs Halmos discusses the significance of the FDA approval of the subcutaneous injection formulation of Opdivo for ...

At my routine oncology checkup, I regretted not bringing my husband when an unexpected medication changes left me feeling ...

Adding hyperthermic intraperitoneal chemotherapy to surgery did not improve progression-free survival in platinum-sensitive recurrent ovarian cancer.

After experiencing unexplained symptoms, I was diagnosed with multiple myeloma and underwent a stem cell transplant.

P1101 had durable hematologic responses and manageable safety among patients with essential thrombocythemia, meeting the ...

When I recognize my frustration and dissapointment with the test results for my chronic lymphocytic leukemia, I find comfort ...

Every treatment bag should include an unlimited supply of humor. Stuff will happen. It’ll be hard, but you may learn to laugh ...